{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:32:05Z","timestamp":1793878325812,"version":"4.7.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","doi-asserted-by":"crossref","award":["W81XWH-07-2-067"],"award-info":[{"award-number":["W81XWH-07-2-067"]}],"id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"crossref"}]},{"name":"U.S. Army Medical Research and Materiel Command (MRMC)"},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["1DP1DA034787-01"],"award-info":[{"award-number":["1DP1DA034787-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH Intramural Research Programs of the National Institute on Drug Abuse"},{"DOI":"10.13039\/100000027","name":"National Institute of Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH"},{"name":"DHHS"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2014.01.028","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T14:31:10Z","timestamp":1391005870000},"page":"1473-1479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Facial recognition of heroin vaccine opiates: Type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine"],"prefix":"10.1016","volume":"32","author":[{"given":"Gary R.","family":"Matyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua F.G.","family":"Antoline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malliga R.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur E.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Mayorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar B.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl R.","family":"Alving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2014.01.028_bib0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.5.4.7556","article-title":"Vaccines against morphine\/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors","volume":"5","author":"Anton","year":"2009","journal-title":"Hum Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2014.01.028_bib0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/icb.2009.17","article-title":"Vaccines against drug abuse. Anti-drug vaccines to treat substance abuse","volume":"87","author":"Kinsey","year":"2009","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.01.028_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2011.281","article-title":"Vaccines against drug abuse","volume":"91","author":"Shen","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2014.01.028_bib0020","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/187152711799219316","article-title":"Developing a vaccine against multiple psychoactive targets: a case study of heroin","volume":"10","author":"Stowe","year":"2011","journal-title":"Neurol Disord Drug Targets"},{"key":"10.1016\/j.vaccine.2014.01.028_bib0025","series-title":"Immunology","first-page":"65","article-title":"Antibodies","author":"Turner","year":"2011"},{"issue":"8","key":"10.1016\/j.vaccine.2014.01.028_bib0030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0161-5890(81)90067-5","article-title":"The concepts of crossreactivity and specificity in immunology","volume":"18","author":"Berzofsky","year":"1981","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2014.01.028_bib0035","series-title":"Fundamental immunology","first-page":"183","article-title":"Antigen-antibody interactions and monoclonal antibodies","author":"Berzofsky","year":"2013"},{"key":"10.1016\/j.vaccine.2014.01.028_bib0040","series-title":"Fundamental immunology","first-page":"539","article-title":"Immunogenicity and antigen structure","author":"Berzofsky","year":"2013"},{"issue":"14","key":"10.1016\/j.vaccine.2014.01.028_bib0045","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.vaccine.2014.01.028_bib0050","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"PNAS"},{"issue":"23","key":"10.1016\/j.vaccine.2014.01.028_bib0055","doi-asserted-by":"crossref","first-page":"10776","DOI":"10.1021\/jm301262z","article-title":"Investigating the effects of a hydrolytically stable hapten and a Th1 adjuvant on heroin vaccine performance","volume":"55","author":"Bremer","year":"2012","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2014.01.028_bib0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1586\/erv.12.35","article-title":"Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines","volume":"11","author":"Alving","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.01.028_bib0065","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.vaccine.2013.04.027","article-title":"Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs","volume":"31","author":"Matyas","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.028_bib0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0076-6879(03)73003-1","article-title":"Oil-in-water liposomal emulsions for vaccine delivery","volume":"373","author":"Matyas","year":"2003","journal-title":"Methods Enzymol"},{"issue":"Suppl 41","key":"10.1016\/j.vaccine.2014.01.028_bib0075","first-page":"8.9.1","article-title":"Models of nociception: hot plate, tail-flick, and formalin tests","author":"Bannon","year":"2007","journal-title":"Curr Protoc Neurosci"},{"issue":"1-2","key":"10.1016\/j.vaccine.2014.01.028_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2011.02.011","article-title":"Applications and recent developments of multi-analyte simultaneous analysis by enzyme-linked immunosorbent assays","volume":"368","author":"Zhang","year":"2011","journal-title":"J Immunol Methods"},{"issue":"16","key":"10.1016\/j.vaccine.2014.01.028_bib0085","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.028_bib0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pnpbp.2013.05.012","article-title":"A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats","volume":"45","author":"Kosten","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.028_bib0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T01:51:21Z","timestamp":1538877081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":19,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X14000607"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facial recognition of heroin vaccine opiates: Type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}